Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
HHS Interagency PEPFAR working group Committee, Work group, Advisory group, or Task Force Not Reported OD/DPCPSI/OAR HHS OGA convenes this (monthly/ad hoc) meeting of the HHS implementing agencies (including CDC, HRSA, FDA, and NIH) to discuss relevant PEPFAR-related updates/activities.  These have included:Ambassador Nkengesong’s updated vision for PEPFAR (5-year Strategy 2022), https://www.state.gov/pepfar-five-year-strategy-2022/Reform of Country Operating Plans (COP)Guidance for agencies’ annual submission of Headquarters Operating Plans (HOPs)Annual PEPFAR meeting and IAS/AIDS 2022Plans for Global-Domestic Bidirectional Learning Forum, etc.
HHS Interagency Veterans Advisory Council Meeting/ Workshop Not Reported OD/OM, OD/OM/OHR Inter-Federal government meeting to formally discuss the various advantages and practices in hiring Veterans. 
HHS Language Access Steering Committee Committee, Work group, Advisory group, or Task Force Not Reported OD/OER HHS is relaunching its Language Access Steering Committee (Steering Committee) to support HHS’s implementation of language access obligations under President Joe Biden’s recent Executive Orders (EOs), as well as similar obligations under the HHS Equity Action Plan. As part of this Steering Committee, all HHS agencies will reassess and update their language access plans to ensure that LEP persons have meaningful access to HHS-administered health and human services programs and activities.
HHS LGBTQI+ Coordinating Committee Committee, Work group, Advisory group, or Task Force ACF, ACL, AHRQ, ASA, ASPR, CDC, CMS, DAB, FDA, HRSA, IHS, IOS, OASH, OCR, OGC, OGA, OIG, OMHA, SAMHSA NIAID, OD/DPCPSI/SGMRO The HHS LGBTQI+ Coordinating Committee is a venue for establishing and strengthening collaboration and communication across the department in the context of SGM health, human services, policy, research, and other relevant emerging issues.
HHS Liaison to NASA Other FDA NCATS, OD/IMOD As HHS Liaison to NASA, Dr. Rutter and her team at NCATS coordinate interactions and expertise sharing among components of HHS to explore joint areas of interest. In January 2021, HHS appointed staff members to centralize the partnership and ensure continuity between administrations. NCATS remains as a leader in these efforts, working alongside NASA and HHS staff to coordinate activities, such as the Tissues Chips in Space Program.
HHS Maternal Health Working Group Committee, Work group, Advisory group, or Task Force ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA NHLBI, NICHD, NIMHD, OD/DPCPSI/ORWH This internal Department of Health and Human Services (HHS) group was formed in June 2019, with the goal of developing a trans-HHS Action Plan aimed at making the U.S. the safest place in the world to give birth.
HHS Maternal Morbidity and Mortality Steering Committee Committee, Work group, Advisory group, or Task Force OASH OD/DPCPSI/ORWH Dr. Clayton has been a member of this committee since 2018.
HHS Minority Health Offices Directors Committee Committee, Work group, Advisory group, or Task Force Not Reported NIMHD The directors of the HHS Offices of Minority Health meet monthly to discuss issues for coordination/collaboration related to minority health and health disparities in their respective agencies to leverage partnerships, foster cross-agency collaborations and share updates.
HHS NASEM Cannabis Science Policy Study Update Meetings Resource Development CDC NCCIH, NCI, NIDA NASEM is funded by CDC and NIH to develop report on impact of different state legalization policies for cannabis, including research priorities. 
HHS NASEM Prevention Infrastructure Study Update Meeting Resource Development CDC, SAMHSA NIDA NASEM Prevention infrastructure study